Logout
If you want to log out click in LogOut
Anti-apoptotic factors are essential in helping cells live longer by preventing programmed cell death, also known as apoptosis. At AnyGenes, we recognize the significance of these factors in cellular health. Our products are specifically designed to support research in understanding anti-apoptotic mechanisms and their impact on cell longevity.
These factors act as protectors, ensuring that cells can survive stressful conditions that would otherwise trigger their demise. In the complex network of cellular processes, anti-apoptotic factors play a key role in keeping tissues and organs healthy. They achieve this by interacting with various signaling pathways and molecular mechanisms that inhibit the apoptotic process, thereby promoting cell survival and function.
Discover our advanced qPCR arrays for Anti-Apoptotic Factors research.
Apoptosis, or programmed cell death, is a highly regulated process that enables the body to remove damaged or unnecessary cells. This process is crucial for maintaining cellular homeostasis and preventing the development of diseases.
During apoptosis, cells undergo a series of orchestrated events leading to their death, including the activation of specific enzymes, DNA fragmentation, and the formation of apoptotic bodies. Apoptosis is essential for various physiological processes such as embryonic development, immune response, and tissue remodeling.
Several key signaling pathways involve anti-apoptotic factors, including the PI3K/AKT pathway, the NF-κB pathway, and the Bcl-2 family of proteins. These pathways play a significant role in regulating the balance between cell survival and apoptosis.
The PI3K/AKT pathway is one of the most well-studied signaling pathways that promote cell survival. Activation of this pathway leads to the inhibition of pro-apoptotic factors and the activation of anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, thereby preventing apoptosis.
The NF-κB pathway is another critical pathway that promotes cell survival by inducing the expression of anti-apoptotic genes. Activation of NF-κB leads to the transcription of various survival genes, which inhibit the apoptotic process and enhance cellular longevity.
Anti-apoptotic genes play a crucial role in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. In cancer, the overexpression of anti-apoptotic genes can lead to uncontrolled cell proliferation and resistance to chemotherapy.
Targeting anti-apoptotic factors has become a promising therapeutic strategy for treating various diseases. Inhibitors of anti-apoptotic proteins, such as Bcl-2 inhibitors, are being developed and tested in clinical trials for their potential to induce apoptosis in cancer cells and improve treatment outcomes
Future research on anti-apoptotic factors holds great promise for developing novel therapeutics for a wide range of diseases. Advances in our understanding of the molecular mechanisms underlying apoptosis and anti-apoptotic signaling pathways will provide new opportunities for targeted therapies.
Emerging technologies, such as gene editing and personalized medicine, have the potential to revolutionize the treatment of diseases associated with dysregulated apoptosis. These technologies could enable precise modulation of anti-apoptotic factors, thereby restoring the balance between cell survival and death and improving patient outcomes.
Scientific data is only as powerful as the analysis behind it.
AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.
What does it allow you to do?
Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
[email protected]
to initiate your project.
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Anti-Apoptotic Factors | AAF1H1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Anti-Apoptotic Factors | ******* |
Biomarker list in progress. |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Anti-Apoptotic Factors | ******* |
Biomarker list in progress. |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Anti-Apoptotic Factors | ******* |
Biomarker list in progress. |
Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.
1. Fulda, S., Debatin, K. M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. (2006)25(34), 4798-4811.
2. Brunelle, J. K., Letai, A. Control of mitochondrial apoptosis by the Bcl-2 family. Journal of Cell Science. (2009)122(4), 437-441.
3. Danial, N. N., Korsmeyer, S. J. Cell death: critical control points. Cell. (2004) 116(2), 205-219.
4. Kaloni, D et al. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. (2023) Feb;28(1-2):20-38.